The heightened susceptibility to mutagenesis and disrupted transcriptional regulation observed in ATRX-deficient gliomas, sarcomas, and other neuroendocrine tumours suggests that similar mechanisms could contribute to the aggressive and proliferative behaviours seen in rare PitNET subtypes. The gene discussed is ATRX; the disease is neuroendocrine neoplasm.